nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP3A5—Ifosfamide—germ cell cancer	0.0786	0.161	CbGbCtD
Lapatinib—CYP2C8—Ifosfamide—germ cell cancer	0.0756	0.155	CbGbCtD
Lapatinib—CYP2C19—Ifosfamide—germ cell cancer	0.0634	0.13	CbGbCtD
Lapatinib—ABCB1—Dactinomycin—germ cell cancer	0.0433	0.0886	CbGbCtD
Lapatinib—CYP3A5—Etoposide—germ cell cancer	0.0376	0.0769	CbGbCtD
Lapatinib—CYP2C8—Etoposide—germ cell cancer	0.0361	0.0739	CbGbCtD
Lapatinib—CYP3A4—Ifosfamide—germ cell cancer	0.0306	0.0627	CbGbCtD
Lapatinib—ABCB1—Vinblastine—germ cell cancer	0.0271	0.0555	CbGbCtD
Lapatinib—ABCB1—Cisplatin—germ cell cancer	0.0249	0.0509	CbGbCtD
Lapatinib—ABCB1—Etoposide—germ cell cancer	0.0244	0.05	CbGbCtD
Lapatinib—CYP3A4—Vinblastine—germ cell cancer	0.0163	0.0333	CbGbCtD
Lapatinib—ABCB1—Methotrexate—germ cell cancer	0.0161	0.0331	CbGbCtD
Lapatinib—CYP3A4—Etoposide—germ cell cancer	0.0146	0.03	CbGbCtD
Lapatinib—Ejection fraction decreased—Ifosfamide—germ cell cancer	0.00919	0.053	CcSEcCtD
Lapatinib—Metastatic neoplasm—Cisplatin—germ cell cancer	0.00679	0.0391	CcSEcCtD
Lapatinib—Cardiotoxicity—Ifosfamide—germ cell cancer	0.0064	0.0369	CcSEcCtD
Lapatinib—Cardiotoxicity—Etoposide—germ cell cancer	0.00506	0.0292	CcSEcCtD
Lapatinib—Paronychia—Methotrexate—germ cell cancer	0.00412	0.0237	CcSEcCtD
Lapatinib—TAP1—trigeminal ganglion—germ cell cancer	0.00377	0.0247	CbGeAlD
Lapatinib—PIK3C2B—trigeminal ganglion—germ cell cancer	0.00354	0.0232	CbGeAlD
Lapatinib—Mucosal inflammation—Bleomycin—germ cell cancer	0.00319	0.0184	CcSEcCtD
Lapatinib—ERBB2—neck—germ cell cancer	0.00319	0.0209	CbGeAlD
Lapatinib—TAP1—decidua—germ cell cancer	0.0028	0.0184	CbGeAlD
Lapatinib—PIK3C2B—telencephalon—germ cell cancer	0.00278	0.0182	CbGeAlD
Lapatinib—Mucosal inflammation—Ifosfamide—germ cell cancer	0.00273	0.0157	CcSEcCtD
Lapatinib—Nail disorder—Bleomycin—germ cell cancer	0.00272	0.0157	CcSEcCtD
Lapatinib—ERBB2—embryo—germ cell cancer	0.00266	0.0174	CbGeAlD
Lapatinib—ERBB4—embryo—germ cell cancer	0.00266	0.0174	CbGeAlD
Lapatinib—PIK3C2B—decidua—germ cell cancer	0.00263	0.0173	CbGeAlD
Lapatinib—PIK3C2B—Vindesine—Vinblastine—germ cell cancer	0.00258	0.301	CbGdCrCtD
Lapatinib—PI4KB—trigeminal ganglion—germ cell cancer	0.00258	0.0169	CbGeAlD
Lapatinib—CYP2C19—urine—germ cell cancer	0.00256	0.0168	CbGeAlD
Lapatinib—Interstitial lung disease—Bleomycin—germ cell cancer	0.00249	0.0144	CcSEcCtD
Lapatinib—ERBB4—brainstem—germ cell cancer	0.00243	0.016	CbGeAlD
Lapatinib—TAP1—pituitary gland—germ cell cancer	0.00241	0.0158	CbGeAlD
Lapatinib—Nail disorder—Ifosfamide—germ cell cancer	0.00233	0.0134	CcSEcCtD
Lapatinib—TAP1—medulla oblongata—germ cell cancer	0.00232	0.0153	CbGeAlD
Lapatinib—PIK3C2B—pituitary gland—germ cell cancer	0.00226	0.0149	CbGeAlD
Lapatinib—PIK3C2B—medulla oblongata—germ cell cancer	0.00218	0.0143	CbGeAlD
Lapatinib—ERBB4—telencephalon—germ cell cancer	0.00216	0.0142	CbGeAlD
Lapatinib—Mucosal inflammation—Etoposide—germ cell cancer	0.00215	0.0124	CcSEcCtD
Lapatinib—TAP1—adrenal gland—germ cell cancer	0.00215	0.0141	CbGeAlD
Lapatinib—Hepatotoxicity—Dactinomycin—germ cell cancer	0.00213	0.0123	CcSEcCtD
Lapatinib—Interstitial lung disease—Ifosfamide—germ cell cancer	0.00213	0.0123	CcSEcCtD
Lapatinib—TAP1—midbrain—germ cell cancer	0.00212	0.014	CbGeAlD
Lapatinib—TAP1—bone marrow—germ cell cancer	0.00208	0.0137	CbGeAlD
Lapatinib—TAP1—spinal cord—germ cell cancer	0.00207	0.0136	CbGeAlD
Lapatinib—ERBB2—skin of body—germ cell cancer	0.00206	0.0135	CbGeAlD
Lapatinib—ERBB2—decidua—germ cell cancer	0.00205	0.0134	CbGeAlD
Lapatinib—PI4KB—telencephalon—germ cell cancer	0.00202	0.0133	CbGeAlD
Lapatinib—PIK3C2B—adrenal gland—germ cell cancer	0.00202	0.0133	CbGeAlD
Lapatinib—TAP1—female gonad—germ cell cancer	0.00201	0.0132	CbGeAlD
Lapatinib—PIK3C2B—midbrain—germ cell cancer	0.00199	0.0131	CbGeAlD
Lapatinib—PIK3C2B—bone marrow—germ cell cancer	0.00195	0.0128	CbGeAlD
Lapatinib—Hepatotoxicity—Ifosfamide—germ cell cancer	0.00195	0.0113	CcSEcCtD
Lapatinib—PIK3C2B—spinal cord—germ cell cancer	0.00195	0.0128	CbGeAlD
Lapatinib—PI4KB—decidua—germ cell cancer	0.00192	0.0126	CbGeAlD
Lapatinib—PIK3C2B—female gonad—germ cell cancer	0.00188	0.0124	CbGeAlD
Lapatinib—Nail disorder—Etoposide—germ cell cancer	0.00184	0.0106	CcSEcCtD
Lapatinib—EGFR—telencephalon—germ cell cancer	0.00183	0.012	CbGeAlD
Lapatinib—ERBB2—gonad—germ cell cancer	0.0018	0.0118	CbGeAlD
Lapatinib—ERBB2—uterus—germ cell cancer	0.00179	0.0118	CbGeAlD
Lapatinib—TAP1—testis—germ cell cancer	0.00178	0.0117	CbGeAlD
Lapatinib—Neoplasm malignant—Ifosfamide—germ cell cancer	0.00177	0.0102	CcSEcCtD
Lapatinib—ERBB4—pituitary gland—germ cell cancer	0.00176	0.0116	CbGeAlD
Lapatinib—PIK3C2B—endocrine gland—germ cell cancer	0.00175	0.0115	CbGeAlD
Lapatinib—PIK3C2B—head—germ cell cancer	0.00173	0.0114	CbGeAlD
Lapatinib—ERBB4—medulla oblongata—germ cell cancer	0.0017	0.0111	CbGeAlD
Lapatinib—PI4KB—gonad—germ cell cancer	0.00169	0.0111	CbGeAlD
Lapatinib—Hepatotoxicity—Cisplatin—germ cell cancer	0.00168	0.00971	CcSEcCtD
Lapatinib—Interstitial lung disease—Etoposide—germ cell cancer	0.00168	0.00971	CcSEcCtD
Lapatinib—PI4KB—uterus—germ cell cancer	0.00168	0.011	CbGeAlD
Lapatinib—PIK3C2B—testis—germ cell cancer	0.00167	0.011	CbGeAlD
Lapatinib—PI4KB—pituitary gland—germ cell cancer	0.00165	0.0108	CbGeAlD
Lapatinib—TAP1—cerebellum—germ cell cancer	0.00164	0.0108	CbGeAlD
Lapatinib—PIK3C2B—Vinorelbine—Vinblastine—germ cell cancer	0.00163	0.19	CbGdCrCtD
Lapatinib—PIK3C2B—Podofilox—Etoposide—germ cell cancer	0.00163	0.19	CbGdCrCtD
Lapatinib—PI4KB—medulla oblongata—germ cell cancer	0.00159	0.0104	CbGeAlD
Lapatinib—ERBB2—adrenal gland—germ cell cancer	0.00157	0.0103	CbGeAlD
Lapatinib—ERBB4—midbrain—germ cell cancer	0.00155	0.0102	CbGeAlD
Lapatinib—Hepatotoxicity—Etoposide—germ cell cancer	0.00154	0.0089	CcSEcCtD
Lapatinib—PIK3C2B—cerebellum—germ cell cancer	0.00154	0.0101	CbGeAlD
Lapatinib—EGFR—uterus—germ cell cancer	0.00152	0.00997	CbGeAlD
Lapatinib—ERBB4—spinal cord—germ cell cancer	0.00151	0.00994	CbGeAlD
Lapatinib—CYP3A4—urine—germ cell cancer	0.00151	0.00993	CbGeAlD
Lapatinib—PI4KB—adrenal gland—germ cell cancer	0.00147	0.00966	CbGeAlD
Lapatinib—ERBB2—female gonad—germ cell cancer	0.00147	0.00962	CbGeAlD
Lapatinib—PI4KB—midbrain—germ cell cancer	0.00145	0.00954	CbGeAlD
Lapatinib—PI4KB—bone marrow—germ cell cancer	0.00142	0.00935	CbGeAlD
Lapatinib—PI4KB—spinal cord—germ cell cancer	0.00142	0.00931	CbGeAlD
Lapatinib—PIK3C2B—Vincristine—Vinblastine—germ cell cancer	0.00139	0.162	CbGdCrCtD
Lapatinib—PI4KB—female gonad—germ cell cancer	0.00137	0.00901	CbGeAlD
Lapatinib—ERBB2—endocrine gland—germ cell cancer	0.00136	0.00895	CbGeAlD
Lapatinib—ERBB4—endocrine gland—germ cell cancer	0.00136	0.00895	CbGeAlD
Lapatinib—ERBB2—head—germ cell cancer	0.00135	0.00883	CbGeAlD
Lapatinib—ERBB4—head—germ cell cancer	0.00135	0.00883	CbGeAlD
Lapatinib—ERBB2—Podofilox—Etoposide—germ cell cancer	0.00134	0.156	CbGdCrCtD
Lapatinib—TAP1—brain—germ cell cancer	0.00134	0.00877	CbGeAlD
Lapatinib—EGFR—adrenal gland—germ cell cancer	0.00133	0.00875	CbGeAlD
Lapatinib—ERBB2—testis—germ cell cancer	0.0013	0.00853	CbGeAlD
Lapatinib—ERBB4—testis—germ cell cancer	0.0013	0.00853	CbGeAlD
Lapatinib—TAP1—lymph node—germ cell cancer	0.00129	0.00847	CbGeAlD
Lapatinib—Mucosal inflammation—Methotrexate—germ cell cancer	0.00129	0.00743	CcSEcCtD
Lapatinib—PI4KB—endocrine gland—germ cell cancer	0.00128	0.00838	CbGeAlD
Lapatinib—PI4KB—head—germ cell cancer	0.00126	0.00827	CbGeAlD
Lapatinib—PIK3C2B—brain—germ cell cancer	0.00125	0.00823	CbGeAlD
Lapatinib—EGFR—female gonad—germ cell cancer	0.00124	0.00816	CbGeAlD
Lapatinib—PI4KB—testis—germ cell cancer	0.00122	0.00799	CbGeAlD
Lapatinib—PIK3C2B—lymph node—germ cell cancer	0.00121	0.00795	CbGeAlD
Lapatinib—ERBB2—cerebellum—germ cell cancer	0.0012	0.00788	CbGeAlD
Lapatinib—ERBB4—cerebellum—germ cell cancer	0.0012	0.00788	CbGeAlD
Lapatinib—Renal failure acute—Ifosfamide—germ cell cancer	0.00119	0.00684	CcSEcCtD
Lapatinib—Neuropathy peripheral—Vinblastine—germ cell cancer	0.00115	0.00661	CcSEcCtD
Lapatinib—PI4KB—cerebellum—germ cell cancer	0.00112	0.00738	CbGeAlD
Lapatinib—Cardiac failure—Ifosfamide—germ cell cancer	0.00112	0.00647	CcSEcCtD
Lapatinib—EGFR—testis—germ cell cancer	0.0011	0.00723	CbGeAlD
Lapatinib—Nail disorder—Methotrexate—germ cell cancer	0.0011	0.00635	CcSEcCtD
Lapatinib—Pain in extremity—Ifosfamide—germ cell cancer	0.0011	0.00632	CcSEcCtD
Lapatinib—Renal failure acute—Cisplatin—germ cell cancer	0.00102	0.0059	CcSEcCtD
Lapatinib—EGFR—cerebellum—germ cell cancer	0.00102	0.00668	CbGeAlD
Lapatinib—Interstitial lung disease—Methotrexate—germ cell cancer	0.00101	0.00582	CcSEcCtD
Lapatinib—Pneumonia—Bleomycin—germ cell cancer	0.000994	0.00573	CcSEcCtD
Lapatinib—ERBB2—brain—germ cell cancer	0.000975	0.0064	CbGeAlD
Lapatinib—ERBB4—brain—germ cell cancer	0.000975	0.0064	CbGeAlD
Lapatinib—Neutropenia—Dactinomycin—germ cell cancer	0.000966	0.00557	CcSEcCtD
Lapatinib—Stomatitis—Bleomycin—germ cell cancer	0.000963	0.00555	CcSEcCtD
Lapatinib—ERBB2—lymph node—germ cell cancer	0.000942	0.00619	CbGeAlD
Lapatinib—Alopecia—Vinblastine—germ cell cancer	0.000928	0.00535	CcSEcCtD
Lapatinib—Pneumonia—Dactinomycin—germ cell cancer	0.000927	0.00534	CcSEcCtD
Lapatinib—Hepatotoxicity—Methotrexate—germ cell cancer	0.000925	0.00533	CcSEcCtD
Lapatinib—PI4KB—brain—germ cell cancer	0.000913	0.006	CbGeAlD
Lapatinib—Stomatitis—Dactinomycin—germ cell cancer	0.000898	0.00518	CcSEcCtD
Lapatinib—Cardiac failure—Etoposide—germ cell cancer	0.000887	0.00511	CcSEcCtD
Lapatinib—PI4KB—lymph node—germ cell cancer	0.000882	0.00579	CbGeAlD
Lapatinib—Dehydration—Cisplatin—germ cell cancer	0.000878	0.00506	CcSEcCtD
Lapatinib—Pneumonia—Ifosfamide—germ cell cancer	0.000849	0.0049	CcSEcCtD
Lapatinib—Anaemia—Vinblastine—germ cell cancer	0.000845	0.00487	CcSEcCtD
Lapatinib—Infestation NOS—Ifosfamide—germ cell cancer	0.000844	0.00487	CcSEcCtD
Lapatinib—Infestation—Ifosfamide—germ cell cancer	0.000844	0.00487	CcSEcCtD
Lapatinib—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.000828	0.00477	CcSEcCtD
Lapatinib—EGFR—brain—germ cell cancer	0.000826	0.00543	CbGeAlD
Lapatinib—Stomatitis—Ifosfamide—germ cell cancer	0.000823	0.00474	CcSEcCtD
Lapatinib—Leukopenia—Vinblastine—germ cell cancer	0.000818	0.00472	CcSEcCtD
Lapatinib—EGFR—lymph node—germ cell cancer	0.000799	0.00524	CbGeAlD
Lapatinib—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.000798	0.0046	CcSEcCtD
Lapatinib—Hyperbilirubinaemia—Methotrexate—germ cell cancer	0.000785	0.00453	CcSEcCtD
Lapatinib—Alopecia—Bleomycin—germ cell cancer	0.000784	0.00452	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Etoposide—germ cell cancer	0.000763	0.0044	CcSEcCtD
Lapatinib—Connective tissue disorder—Ifosfamide—germ cell cancer	0.000745	0.00429	CcSEcCtD
Lapatinib—Alopecia—Dactinomycin—germ cell cancer	0.000731	0.00421	CcSEcCtD
Lapatinib—Anaemia—Bleomycin—germ cell cancer	0.000713	0.00411	CcSEcCtD
Lapatinib—Neuropathy peripheral—Cisplatin—germ cell cancer	0.000713	0.00411	CcSEcCtD
Lapatinib—Anorexia—Vinblastine—germ cell cancer	0.000711	0.0041	CcSEcCtD
Lapatinib—Stomatitis—Cisplatin—germ cell cancer	0.000709	0.00409	CcSEcCtD
Lapatinib—Cardiac disorder—Ifosfamide—germ cell cancer	0.000703	0.00405	CcSEcCtD
Lapatinib—Neutropenia—Etoposide—germ cell cancer	0.000699	0.00403	CcSEcCtD
Lapatinib—Leukopenia—Bleomycin—germ cell cancer	0.000691	0.00398	CcSEcCtD
Lapatinib—Hepatobiliary disease—Cisplatin—germ cell cancer	0.000688	0.00397	CcSEcCtD
Lapatinib—Angiopathy—Ifosfamide—germ cell cancer	0.000688	0.00396	CcSEcCtD
Lapatinib—Immune system disorder—Ifosfamide—germ cell cancer	0.000685	0.00395	CcSEcCtD
Lapatinib—Mediastinal disorder—Ifosfamide—germ cell cancer	0.000683	0.00394	CcSEcCtD
Lapatinib—Cough—Bleomycin—germ cell cancer	0.000674	0.00388	CcSEcCtD
Lapatinib—Pneumonia—Etoposide—germ cell cancer	0.000671	0.00387	CcSEcCtD
Lapatinib—Alopecia—Ifosfamide—germ cell cancer	0.00067	0.00386	CcSEcCtD
Lapatinib—Infestation—Etoposide—germ cell cancer	0.000667	0.00384	CcSEcCtD
Lapatinib—Infestation NOS—Etoposide—germ cell cancer	0.000667	0.00384	CcSEcCtD
Lapatinib—Anaemia—Dactinomycin—germ cell cancer	0.000665	0.00384	CcSEcCtD
Lapatinib—Mental disorder—Ifosfamide—germ cell cancer	0.000664	0.00383	CcSEcCtD
Lapatinib—Malnutrition—Ifosfamide—germ cell cancer	0.00066	0.0038	CcSEcCtD
Lapatinib—Myalgia—Bleomycin—germ cell cancer	0.000657	0.00379	CcSEcCtD
Lapatinib—Neuropathy peripheral—Etoposide—germ cell cancer	0.000654	0.00377	CcSEcCtD
Lapatinib—Stomatitis—Etoposide—germ cell cancer	0.00065	0.00375	CcSEcCtD
Lapatinib—Decreased appetite—Vinblastine—germ cell cancer	0.000648	0.00374	CcSEcCtD
Lapatinib—Leukopenia—Dactinomycin—germ cell cancer	0.000644	0.00372	CcSEcCtD
Lapatinib—Connective tissue disorder—Cisplatin—germ cell cancer	0.000642	0.0037	CcSEcCtD
Lapatinib—Constipation—Vinblastine—germ cell cancer	0.000638	0.00368	CcSEcCtD
Lapatinib—Hepatobiliary disease—Etoposide—germ cell cancer	0.000631	0.00364	CcSEcCtD
Lapatinib—Anaphylactic shock—Bleomycin—germ cell cancer	0.00063	0.00363	CcSEcCtD
Lapatinib—Infection—Bleomycin—germ cell cancer	0.000626	0.00361	CcSEcCtD
Lapatinib—Myalgia—Dactinomycin—germ cell cancer	0.000613	0.00353	CcSEcCtD
Lapatinib—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00061	0.00352	CcSEcCtD
Lapatinib—Anaemia—Ifosfamide—germ cell cancer	0.00061	0.00352	CcSEcCtD
Lapatinib—Cardiac disorder—Cisplatin—germ cell cancer	0.000606	0.0035	CcSEcCtD
Lapatinib—Anorexia—Bleomycin—germ cell cancer	0.000601	0.00346	CcSEcCtD
Lapatinib—Leukopenia—Ifosfamide—germ cell cancer	0.000591	0.0034	CcSEcCtD
Lapatinib—Immune system disorder—Cisplatin—germ cell cancer	0.00059	0.0034	CcSEcCtD
Lapatinib—Abdominal pain—Vinblastine—germ cell cancer	0.00059	0.0034	CcSEcCtD
Lapatinib—Mediastinal disorder—Cisplatin—germ cell cancer	0.000589	0.00339	CcSEcCtD
Lapatinib—Infection—Dactinomycin—germ cell cancer	0.000584	0.00337	CcSEcCtD
Lapatinib—Palpitations—Ifosfamide—germ cell cancer	0.000583	0.00336	CcSEcCtD
Lapatinib—ABCB1—blood vessel—germ cell cancer	0.00058	0.00381	CbGeAlD
Lapatinib—Alopecia—Cisplatin—germ cell cancer	0.000577	0.00333	CcSEcCtD
Lapatinib—Cough—Ifosfamide—germ cell cancer	0.000576	0.00332	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000574	0.00331	CcSEcCtD
Lapatinib—Malnutrition—Cisplatin—germ cell cancer	0.000569	0.00328	CcSEcCtD
Lapatinib—Dyspnoea—Bleomycin—germ cell cancer	0.000562	0.00324	CcSEcCtD
Lapatinib—Arthralgia—Ifosfamide—germ cell cancer	0.000562	0.00324	CcSEcCtD
Lapatinib—Myalgia—Ifosfamide—germ cell cancer	0.000562	0.00324	CcSEcCtD
Lapatinib—Renal failure acute—Methotrexate—germ cell cancer	0.000561	0.00324	CcSEcCtD
Lapatinib—Anorexia—Dactinomycin—germ cell cancer	0.00056	0.00323	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000558	0.00322	CcSEcCtD
Lapatinib—Cardiac disorder—Etoposide—germ cell cancer	0.000555	0.0032	CcSEcCtD
Lapatinib—Hypersensitivity—Vinblastine—germ cell cancer	0.00055	0.00317	CcSEcCtD
Lapatinib—Decreased appetite—Bleomycin—germ cell cancer	0.000548	0.00316	CcSEcCtD
Lapatinib—Angiopathy—Etoposide—germ cell cancer	0.000543	0.00313	CcSEcCtD
Lapatinib—Immune system disorder—Etoposide—germ cell cancer	0.000541	0.00312	CcSEcCtD
Lapatinib—Mediastinal disorder—Etoposide—germ cell cancer	0.000539	0.00311	CcSEcCtD
Lapatinib—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000538	0.0031	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000535	0.00309	CcSEcCtD
Lapatinib—Asthenia—Vinblastine—germ cell cancer	0.000535	0.00309	CcSEcCtD
Lapatinib—Infection—Ifosfamide—germ cell cancer	0.000535	0.00308	CcSEcCtD
Lapatinib—Alopecia—Etoposide—germ cell cancer	0.000529	0.00305	CcSEcCtD
Lapatinib—Nervous system disorder—Ifosfamide—germ cell cancer	0.000528	0.00304	CcSEcCtD
Lapatinib—Anaemia—Cisplatin—germ cell cancer	0.000526	0.00303	CcSEcCtD
Lapatinib—Skin disorder—Ifosfamide—germ cell cancer	0.000523	0.00302	CcSEcCtD
Lapatinib—Anorexia—Ifosfamide—germ cell cancer	0.000513	0.00296	CcSEcCtD
Lapatinib—Decreased appetite—Dactinomycin—germ cell cancer	0.000511	0.00294	CcSEcCtD
Lapatinib—Diarrhoea—Vinblastine—germ cell cancer	0.00051	0.00294	CcSEcCtD
Lapatinib—Leukopenia—Cisplatin—germ cell cancer	0.000509	0.00294	CcSEcCtD
Lapatinib—Fatigue—Dactinomycin—germ cell cancer	0.000507	0.00292	CcSEcCtD
Lapatinib—Back pain—Etoposide—germ cell cancer	0.000504	0.00291	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000491	0.00283	CcSEcCtD
Lapatinib—Myalgia—Cisplatin—germ cell cancer	0.000484	0.00279	CcSEcCtD
Lapatinib—Anaemia—Etoposide—germ cell cancer	0.000482	0.00278	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000481	0.00277	CcSEcCtD
Lapatinib—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00048	0.00277	CcSEcCtD
Lapatinib—Dyspnoea—Ifosfamide—germ cell cancer	0.00048	0.00277	CcSEcCtD
Lapatinib—CYP2C8—pituitary gland—germ cell cancer	0.000478	0.00314	CbGeAlD
Lapatinib—Vomiting—Vinblastine—germ cell cancer	0.000474	0.00273	CcSEcCtD
Lapatinib—Decreased appetite—Ifosfamide—germ cell cancer	0.000468	0.0027	CcSEcCtD
Lapatinib—Headache—Vinblastine—germ cell cancer	0.000467	0.00269	CcSEcCtD
Lapatinib—Leukopenia—Etoposide—germ cell cancer	0.000466	0.00269	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000465	0.00268	CcSEcCtD
Lapatinib—Abdominal pain—Dactinomycin—germ cell cancer	0.000464	0.00268	CcSEcCtD
Lapatinib—Fatigue—Ifosfamide—germ cell cancer	0.000464	0.00268	CcSEcCtD
Lapatinib—Anaphylactic shock—Cisplatin—germ cell cancer	0.000464	0.00268	CcSEcCtD
Lapatinib—Hypersensitivity—Bleomycin—germ cell cancer	0.000464	0.00268	CcSEcCtD
Lapatinib—Infection—Cisplatin—germ cell cancer	0.000461	0.00266	CcSEcCtD
Lapatinib—Constipation—Ifosfamide—germ cell cancer	0.00046	0.00265	CcSEcCtD
Lapatinib—Nervous system disorder—Cisplatin—germ cell cancer	0.000455	0.00262	CcSEcCtD
Lapatinib—Cough—Etoposide—germ cell cancer	0.000455	0.00262	CcSEcCtD
Lapatinib—Asthenia—Bleomycin—germ cell cancer	0.000452	0.00261	CcSEcCtD
Lapatinib—Skin disorder—Cisplatin—germ cell cancer	0.000451	0.0026	CcSEcCtD
Lapatinib—Pruritus—Bleomycin—germ cell cancer	0.000446	0.00257	CcSEcCtD
Lapatinib—Nausea—Vinblastine—germ cell cancer	0.000443	0.00255	CcSEcCtD
Lapatinib—Anorexia—Cisplatin—germ cell cancer	0.000442	0.00255	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000441	0.00254	CcSEcCtD
Lapatinib—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00044	0.00254	CcSEcCtD
Lapatinib—Hypersensitivity—Dactinomycin—germ cell cancer	0.000433	0.0025	CcSEcCtD
Lapatinib—Abdominal pain—Ifosfamide—germ cell cancer	0.000426	0.00245	CcSEcCtD
Lapatinib—Anaphylactic shock—Etoposide—germ cell cancer	0.000425	0.00245	CcSEcCtD
Lapatinib—CYP2C19—endocrine gland—germ cell cancer	0.000424	0.00279	CbGeAlD
Lapatinib—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.000423	0.00244	CcSEcCtD
Lapatinib—Infection—Etoposide—germ cell cancer	0.000422	0.00244	CcSEcCtD
Lapatinib—Asthenia—Dactinomycin—germ cell cancer	0.000422	0.00243	CcSEcCtD
Lapatinib—Neutropenia—Methotrexate—germ cell cancer	0.000419	0.00241	CcSEcCtD
Lapatinib—Dyspnoea—Cisplatin—germ cell cancer	0.000414	0.00239	CcSEcCtD
Lapatinib—Skin disorder—Etoposide—germ cell cancer	0.000413	0.00238	CcSEcCtD
Lapatinib—Anorexia—Etoposide—germ cell cancer	0.000405	0.00234	CcSEcCtD
Lapatinib—Decreased appetite—Cisplatin—germ cell cancer	0.000403	0.00233	CcSEcCtD
Lapatinib—Diarrhoea—Dactinomycin—germ cell cancer	0.000402	0.00232	CcSEcCtD
Lapatinib—Pneumonia—Methotrexate—germ cell cancer	0.000402	0.00232	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000401	0.00231	CcSEcCtD
Lapatinib—Vomiting—Bleomycin—germ cell cancer	0.000401	0.00231	CcSEcCtD
Lapatinib—Infestation—Methotrexate—germ cell cancer	0.000399	0.0023	CcSEcCtD
Lapatinib—Infestation NOS—Methotrexate—germ cell cancer	0.000399	0.0023	CcSEcCtD
Lapatinib—Rash—Bleomycin—germ cell cancer	0.000397	0.00229	CcSEcCtD
Lapatinib—Dermatitis—Bleomycin—germ cell cancer	0.000397	0.00229	CcSEcCtD
Lapatinib—Hypersensitivity—Ifosfamide—germ cell cancer	0.000397	0.00229	CcSEcCtD
Lapatinib—Stomatitis—Methotrexate—germ cell cancer	0.000389	0.00224	CcSEcCtD
Lapatinib—Asthenia—Ifosfamide—germ cell cancer	0.000386	0.00223	CcSEcCtD
Lapatinib—Pruritus—Ifosfamide—germ cell cancer	0.000381	0.0022	CcSEcCtD
Lapatinib—Dyspnoea—Etoposide—germ cell cancer	0.000379	0.00219	CcSEcCtD
Lapatinib—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000378	0.00218	CcSEcCtD
Lapatinib—Epistaxis—Methotrexate—germ cell cancer	0.000377	0.00217	CcSEcCtD
Lapatinib—Nausea—Bleomycin—germ cell cancer	0.000374	0.00216	CcSEcCtD
Lapatinib—Vomiting—Dactinomycin—germ cell cancer	0.000374	0.00215	CcSEcCtD
Lapatinib—Rash—Dactinomycin—germ cell cancer	0.00037	0.00214	CcSEcCtD
Lapatinib—CYP2C8—endocrine gland—germ cell cancer	0.00037	0.00243	CbGeAlD
Lapatinib—Decreased appetite—Etoposide—germ cell cancer	0.00037	0.00213	CcSEcCtD
Lapatinib—Diarrhoea—Ifosfamide—germ cell cancer	0.000368	0.00212	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000367	0.00212	CcSEcCtD
Lapatinib—Fatigue—Etoposide—germ cell cancer	0.000367	0.00211	CcSEcCtD
Lapatinib—Constipation—Etoposide—germ cell cancer	0.000364	0.0021	CcSEcCtD
Lapatinib—CYP3A5—female gonad—germ cell cancer	0.000359	0.00236	CbGeAlD
Lapatinib—ABCB1—trigeminal ganglion—germ cell cancer	0.000358	0.00235	CbGeAlD
Lapatinib—CYP2C8—testis—germ cell cancer	0.000353	0.00232	CbGeAlD
Lapatinib—Nausea—Dactinomycin—germ cell cancer	0.000349	0.00201	CcSEcCtD
Lapatinib—Gastrointestinal pain—Etoposide—germ cell cancer	0.000348	0.002	CcSEcCtD
Lapatinib—ABCB1—embryo—germ cell cancer	0.000346	0.00227	CbGeAlD
Lapatinib—Vomiting—Ifosfamide—germ cell cancer	0.000342	0.00197	CcSEcCtD
Lapatinib—Hypersensitivity—Cisplatin—germ cell cancer	0.000342	0.00197	CcSEcCtD
Lapatinib—Rash—Ifosfamide—germ cell cancer	0.000339	0.00196	CcSEcCtD
Lapatinib—Dermatitis—Ifosfamide—germ cell cancer	0.000339	0.00196	CcSEcCtD
Lapatinib—Abdominal pain—Etoposide—germ cell cancer	0.000336	0.00194	CcSEcCtD
Lapatinib—CYP3A5—endocrine gland—germ cell cancer	0.000334	0.00219	CbGeAlD
Lapatinib—Asthenia—Cisplatin—germ cell cancer	0.000333	0.00192	CcSEcCtD
Lapatinib—Cardiac disorder—Methotrexate—germ cell cancer	0.000333	0.00192	CcSEcCtD
Lapatinib—Angiopathy—Methotrexate—germ cell cancer	0.000325	0.00188	CcSEcCtD
Lapatinib—Immune system disorder—Methotrexate—germ cell cancer	0.000324	0.00187	CcSEcCtD
Lapatinib—Mediastinal disorder—Methotrexate—germ cell cancer	0.000323	0.00186	CcSEcCtD
Lapatinib—Nausea—Ifosfamide—germ cell cancer	0.00032	0.00184	CcSEcCtD
Lapatinib—Diarrhoea—Cisplatin—germ cell cancer	0.000318	0.00183	CcSEcCtD
Lapatinib—Alopecia—Methotrexate—germ cell cancer	0.000317	0.00183	CcSEcCtD
Lapatinib—Mental disorder—Methotrexate—germ cell cancer	0.000314	0.00181	CcSEcCtD
Lapatinib—Hypersensitivity—Etoposide—germ cell cancer	0.000313	0.00181	CcSEcCtD
Lapatinib—Malnutrition—Methotrexate—germ cell cancer	0.000312	0.0018	CcSEcCtD
Lapatinib—ABCB1—retina—germ cell cancer	0.000306	0.00201	CbGeAlD
Lapatinib—Asthenia—Etoposide—germ cell cancer	0.000305	0.00176	CcSEcCtD
Lapatinib—Back pain—Methotrexate—germ cell cancer	0.000302	0.00174	CcSEcCtD
Lapatinib—Pruritus—Etoposide—germ cell cancer	0.000301	0.00173	CcSEcCtD
Lapatinib—Vomiting—Cisplatin—germ cell cancer	0.000295	0.0017	CcSEcCtD
Lapatinib—Rash—Cisplatin—germ cell cancer	0.000293	0.00169	CcSEcCtD
Lapatinib—Dermatitis—Cisplatin—germ cell cancer	0.000292	0.00169	CcSEcCtD
Lapatinib—Diarrhoea—Etoposide—germ cell cancer	0.000291	0.00168	CcSEcCtD
Lapatinib—Anaemia—Methotrexate—germ cell cancer	0.000288	0.00166	CcSEcCtD
Lapatinib—ABCB1—telencephalon—germ cell cancer	0.000281	0.00185	CbGeAlD
Lapatinib—Leukopenia—Methotrexate—germ cell cancer	0.000279	0.00161	CcSEcCtD
Lapatinib—Nausea—Cisplatin—germ cell cancer	0.000276	0.00159	CcSEcCtD
Lapatinib—Cough—Methotrexate—germ cell cancer	0.000272	0.00157	CcSEcCtD
Lapatinib—Vomiting—Etoposide—germ cell cancer	0.00027	0.00156	CcSEcCtD
Lapatinib—Rash—Etoposide—germ cell cancer	0.000268	0.00155	CcSEcCtD
Lapatinib—Dermatitis—Etoposide—germ cell cancer	0.000268	0.00154	CcSEcCtD
Lapatinib—ABCB1—decidua—germ cell cancer	0.000267	0.00175	CbGeAlD
Lapatinib—Headache—Etoposide—germ cell cancer	0.000266	0.00154	CcSEcCtD
Lapatinib—Arthralgia—Methotrexate—germ cell cancer	0.000266	0.00153	CcSEcCtD
Lapatinib—Myalgia—Methotrexate—germ cell cancer	0.000266	0.00153	CcSEcCtD
Lapatinib—CYP2C8—brain—germ cell cancer	0.000265	0.00174	CbGeAlD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000264	0.00152	CcSEcCtD
Lapatinib—Anaphylactic shock—Methotrexate—germ cell cancer	0.000255	0.00147	CcSEcCtD
Lapatinib—Infection—Methotrexate—germ cell cancer	0.000253	0.00146	CcSEcCtD
Lapatinib—Nausea—Etoposide—germ cell cancer	0.000253	0.00146	CcSEcCtD
Lapatinib—CYP3A4—endocrine gland—germ cell cancer	0.000251	0.00165	CbGeAlD
Lapatinib—Nervous system disorder—Methotrexate—germ cell cancer	0.00025	0.00144	CcSEcCtD
Lapatinib—Skin disorder—Methotrexate—germ cell cancer	0.000247	0.00143	CcSEcCtD
Lapatinib—Anorexia—Methotrexate—germ cell cancer	0.000243	0.0014	CcSEcCtD
Lapatinib—ABCB1—gonad—germ cell cancer	0.000235	0.00154	CbGeAlD
Lapatinib—ABCB1—uterus—germ cell cancer	0.000233	0.00153	CbGeAlD
Lapatinib—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000232	0.00134	CcSEcCtD
Lapatinib—Insomnia—Methotrexate—germ cell cancer	0.00023	0.00133	CcSEcCtD
Lapatinib—ABCB1—pituitary gland—germ cell cancer	0.000229	0.0015	CbGeAlD
Lapatinib—Dyspnoea—Methotrexate—germ cell cancer	0.000227	0.00131	CcSEcCtD
Lapatinib—Dyspepsia—Methotrexate—germ cell cancer	0.000224	0.00129	CcSEcCtD
Lapatinib—Decreased appetite—Methotrexate—germ cell cancer	0.000221	0.00128	CcSEcCtD
Lapatinib—ABCB1—medulla oblongata—germ cell cancer	0.000221	0.00145	CbGeAlD
Lapatinib—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00022	0.00127	CcSEcCtD
Lapatinib—Fatigue—Methotrexate—germ cell cancer	0.00022	0.00127	CcSEcCtD
Lapatinib—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000208	0.0012	CcSEcCtD
Lapatinib—ABCB1—adrenal gland—germ cell cancer	0.000205	0.00134	CbGeAlD
Lapatinib—ABCB1—midbrain—germ cell cancer	0.000202	0.00133	CbGeAlD
Lapatinib—Abdominal pain—Methotrexate—germ cell cancer	0.000201	0.00116	CcSEcCtD
Lapatinib—ABCB1—bone marrow—germ cell cancer	0.000198	0.0013	CbGeAlD
Lapatinib—ABCB1—spinal cord—germ cell cancer	0.000197	0.00129	CbGeAlD
Lapatinib—ABCB1—female gonad—germ cell cancer	0.000191	0.00125	CbGeAlD
Lapatinib—Hypersensitivity—Methotrexate—germ cell cancer	0.000188	0.00108	CcSEcCtD
Lapatinib—Asthenia—Methotrexate—germ cell cancer	0.000183	0.00105	CcSEcCtD
Lapatinib—Pruritus—Methotrexate—germ cell cancer	0.00018	0.00104	CcSEcCtD
Lapatinib—ERBB4—Immune System—PVRL2—germ cell cancer	0.000178	0.001	CbGpPWpGaD
Lapatinib—ABCB1—endocrine gland—germ cell cancer	0.000178	0.00117	CbGeAlD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—KITLG—germ cell cancer	0.000177	0.001	CbGpPWpGaD
Lapatinib—EGFR—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	0.000176	0.000996	CbGpPWpGaD
Lapatinib—ABCB1—head—germ cell cancer	0.000175	0.00115	CbGeAlD
Lapatinib—Diarrhoea—Methotrexate—germ cell cancer	0.000174	0.001	CcSEcCtD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000173	0.000978	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Actin Cytoskeleton—FGFR3—germ cell cancer	0.000171	0.000963	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—FGFR3—germ cell cancer	0.000171	0.000963	CbGpPWpGaD
Lapatinib—TAP1—Immune System—KIT—germ cell cancer	0.00017	0.00096	CbGpPWpGaD
Lapatinib—ABCB1—testis—germ cell cancer	0.000169	0.00111	CbGeAlD
Lapatinib—EGFR—Signaling by ERBB4—FGFR3—germ cell cancer	0.000168	0.000948	CbGpPWpGaD
Lapatinib—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—germ cell cancer	0.000167	0.000946	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—germ cell cancer	0.000167	0.000944	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—FGF4—germ cell cancer	0.000166	0.000936	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—KIT—germ cell cancer	0.000164	0.000924	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—MYC—germ cell cancer	0.000163	0.000922	CbGpPWpGaD
Lapatinib—Vomiting—Methotrexate—germ cell cancer	0.000162	0.000934	CcSEcCtD
Lapatinib—EGFR—Regulation of Telomerase—MYC—germ cell cancer	0.000161	0.000911	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—KITLG—germ cell cancer	0.000161	0.000907	CbGpPWpGaD
Lapatinib—Rash—Methotrexate—germ cell cancer	0.000161	0.000926	CcSEcCtD
Lapatinib—Dermatitis—Methotrexate—germ cell cancer	0.00016	0.000925	CcSEcCtD
Lapatinib—EGFR—Downstream signal transduction—FGFR3—germ cell cancer	0.00016	0.000905	CbGpPWpGaD
Lapatinib—Headache—Methotrexate—germ cell cancer	0.00016	0.00092	CcSEcCtD
Lapatinib—EGFR—Signaling by FGFR—FGFR3—germ cell cancer	0.000159	0.000901	CbGpPWpGaD
Lapatinib—EGFR—ErbB Signaling Pathway—TP53—germ cell cancer	0.000159	0.0009	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—FGFR3—germ cell cancer	0.000159	0.000896	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—KITLG—germ cell cancer	0.000158	0.000894	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—FGFR3—germ cell cancer	0.000158	0.000892	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—KIT—germ cell cancer	0.000157	0.000884	CbGpPWpGaD
Lapatinib—ABCB1—cerebellum—germ cell cancer	0.000156	0.00103	CbGeAlD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—germ cell cancer	0.000156	0.000879	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—KITLG—germ cell cancer	0.000154	0.000871	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—KIT—germ cell cancer	0.000154	0.00087	CbGpPWpGaD
Lapatinib—EGFR—ErbB Signaling Pathway—HRAS—germ cell cancer	0.000152	0.00086	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—KITLG—germ cell cancer	0.000152	0.000858	CbGpPWpGaD
Lapatinib—Nausea—Methotrexate—germ cell cancer	0.000151	0.000872	CcSEcCtD
Lapatinib—EGFR—DAP12 interactions—FGFR3—germ cell cancer	0.000149	0.000839	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—FGFR3—germ cell cancer	0.000149	0.000839	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—FGFR3—germ cell cancer	0.000149	0.000839	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—FGFR3—germ cell cancer	0.000147	0.000831	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—KIT—germ cell cancer	0.000147	0.000831	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—KIT—germ cell cancer	0.000146	0.000827	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by SCF-KIT—HRAS—germ cell cancer	0.000146	0.000826	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000146	0.000825	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—FGFR3—germ cell cancer	0.000146	0.000824	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—SOX2—germ cell cancer	0.000146	0.000824	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—KIT—germ cell cancer	0.000146	0.000823	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—FGFR3—germ cell cancer	0.000145	0.00082	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—KIT—germ cell cancer	0.000145	0.000819	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by SCF-KIT—HRAS—germ cell cancer	0.000144	0.000814	CbGpPWpGaD
Lapatinib—EGFR—SHP2 signaling—HRAS—germ cell cancer	0.000144	0.000813	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—PVRL2—germ cell cancer	0.000144	0.000811	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KIT—germ cell cancer	0.000143	0.000807	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling of activated FGFR—HRAS—germ cell cancer	0.00014	0.00079	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling of activated FGFR—HRAS—germ cell cancer	0.000138	0.000778	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB4—HRAS—germ cell cancer	0.000138	0.000778	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—FGFR3—germ cell cancer	0.000137	0.000776	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—KIT—germ cell cancer	0.000136	0.00077	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—KIT—germ cell cancer	0.000136	0.00077	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—KIT—germ cell cancer	0.000136	0.00077	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—KITLG—germ cell cancer	0.000136	0.000769	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—HRAS—germ cell cancer	0.000136	0.000766	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—KIT—germ cell cancer	0.000135	0.000763	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—germ cell cancer	0.000134	0.000757	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—KIT—germ cell cancer	0.000134	0.000757	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—KIT—germ cell cancer	0.000133	0.000753	CbGpPWpGaD
Lapatinib—EGFR—LPA receptor mediated events—HRAS—germ cell cancer	0.000133	0.000751	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—FGFR3—germ cell cancer	0.000132	0.000743	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signal transduction—HRAS—germ cell cancer	0.000132	0.000743	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR—HRAS—germ cell cancer	0.000131	0.000739	CbGpPWpGaD
Lapatinib—ERBB2—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	0.000131	0.000739	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB2—HRAS—germ cell cancer	0.00013	0.000735	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—HRAS—germ cell cancer	0.00013	0.000732	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—HRAS—germ cell cancer	0.00013	0.000732	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—HRAS—germ cell cancer	0.000129	0.000728	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—HRAS—germ cell cancer	0.000128	0.000724	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—HRAS—germ cell cancer	0.000128	0.000724	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000128	0.000721	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—HRAS—germ cell cancer	0.000128	0.000721	CbGpPWpGaD
Lapatinib—ABCB1—brain—germ cell cancer	0.000127	0.000834	CbGeAlD
Lapatinib—EGFR—B Cell Activation—KIT—germ cell cancer	0.000126	0.000713	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	0.000126	0.000711	CbGpPWpGaD
Lapatinib—ABCB1—lymph node—germ cell cancer	0.000123	0.000806	CbGeAlD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000122	0.00069	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—HRAS—germ cell cancer	0.000122	0.000689	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	0.000122	0.000689	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—HRAS—germ cell cancer	0.000122	0.000689	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—HRAS—germ cell cancer	0.000121	0.000684	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—HRAS—germ cell cancer	0.000121	0.000682	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—KIT—germ cell cancer	0.000121	0.000682	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—HRAS—germ cell cancer	0.00012	0.000678	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—HRAS—germ cell cancer	0.00012	0.000678	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	0.00012	0.000678	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.00012	0.000677	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—HRAS—germ cell cancer	0.00012	0.000676	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—FGFR3—germ cell cancer	0.000119	0.000674	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—HRAS—germ cell cancer	0.000119	0.000673	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—HRAS—germ cell cancer	0.000119	0.000672	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—HRAS—germ cell cancer	0.000118	0.000666	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—FGFR3—germ cell cancer	0.000118	0.000664	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—HRAS—germ cell cancer	0.000117	0.000663	CbGpPWpGaD
Lapatinib—ERBB2—Focal Adhesion—HRAS—germ cell cancer	0.000115	0.000651	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—FGFR3—germ cell cancer	0.000115	0.000647	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—germ cell cancer	0.000114	0.000644	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—FGF4—germ cell cancer	0.000114	0.000643	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—FGFR3—germ cell cancer	0.000113	0.000638	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—HRAS—germ cell cancer	0.000113	0.000637	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—FGF4—germ cell cancer	0.000112	0.000634	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—HRAS—germ cell cancer	0.000111	0.000628	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—KIT—germ cell cancer	0.00011	0.000619	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—HRAS—germ cell cancer	0.000109	0.000616	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	0.000108	0.00061	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—KIT—germ cell cancer	0.000108	0.00061	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	0.000106	0.000601	CbGpPWpGaD
Lapatinib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	0.000106	0.000598	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—KIT—germ cell cancer	0.000105	0.000594	CbGpPWpGaD
Lapatinib—ERBB2—Disease—FGF4—germ cell cancer	0.000105	0.000594	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—MYC—germ cell cancer	0.000104	0.000586	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—KIT—germ cell cancer	0.000104	0.000586	CbGpPWpGaD
Lapatinib—ERBB4—Disease—FGF4—germ cell cancer	0.000104	0.000585	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—FGFR3—germ cell cancer	0.000101	0.000572	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—FGF4—germ cell cancer	9.45e-05	0.000534	CbGpPWpGaD
Lapatinib—ERBB2—Disease—H2AFZ—germ cell cancer	9.39e-05	0.00053	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—KITLG—germ cell cancer	9.36e-05	0.000528	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—KIT—germ cell cancer	9.29e-05	0.000525	CbGpPWpGaD
Lapatinib—ERBB4—Disease—H2AFZ—germ cell cancer	9.25e-05	0.000522	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—KITLG—germ cell cancer	9.22e-05	0.00052	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—FGF4—germ cell cancer	9.08e-05	0.000513	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—HRAS—germ cell cancer	8.95e-05	0.000505	CbGpPWpGaD
Lapatinib—EGFR—Disease—SLC2A3—germ cell cancer	8.85e-05	0.0005	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PVRL2—germ cell cancer	8.72e-05	0.000492	CbGpPWpGaD
Lapatinib—ERBB2—Disease—KITLG—germ cell cancer	8.64e-05	0.000488	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—OXT—germ cell cancer	8.63e-05	0.000487	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—germ cell cancer	8.53e-05	0.000481	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—MYC—germ cell cancer	8.52e-05	0.000481	CbGpPWpGaD
Lapatinib—ERBB4—Disease—KITLG—germ cell cancer	8.51e-05	0.000481	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—OXT—germ cell cancer	8.5e-05	0.00048	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—HRAS—germ cell cancer	8.31e-05	0.000469	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—HRAS—germ cell cancer	8.18e-05	0.000462	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	7.99e-05	0.000451	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	7.87e-05	0.000444	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—MYC—germ cell cancer	7.83e-05	0.000442	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—KITLG—germ cell cancer	7.77e-05	0.000439	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	7.74e-05	0.000437	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—HRAS—germ cell cancer	7.52e-05	0.000425	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—KITLG—germ cell cancer	7.46e-05	0.000421	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—germ cell cancer	7.44e-05	0.00042	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FGF4—germ cell cancer	7.36e-05	0.000416	CbGpPWpGaD
Lapatinib—TAP1—Immune System—HRAS—germ cell cancer	7.34e-05	0.000415	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FGF4—germ cell cancer	7.25e-05	0.00041	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—HRAS—germ cell cancer	7.07e-05	0.000399	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	7.06e-05	0.000399	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—OXT—germ cell cancer	7.06e-05	0.000399	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—germ cell cancer	7e-05	0.000395	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—FGFR3—germ cell cancer	6.95e-05	0.000393	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	6.91e-05	0.00039	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—FGFR3—germ cell cancer	6.85e-05	0.000387	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—HRAS—germ cell cancer	6.77e-05	0.000382	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—HRAS—germ cell cancer	6.66e-05	0.000376	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—H2AFZ—germ cell cancer	6.58e-05	0.000371	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—H2AFZ—germ cell cancer	6.48e-05	0.000366	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—germ cell cancer	6.43e-05	0.000363	CbGpPWpGaD
Lapatinib—ERBB2—Disease—FGFR3—germ cell cancer	6.42e-05	0.000363	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—KIT—germ cell cancer	6.39e-05	0.000361	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—HRAS—germ cell cancer	6.36e-05	0.000359	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—HRAS—germ cell cancer	6.33e-05	0.000357	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—HRAS—germ cell cancer	6.33e-05	0.000357	CbGpPWpGaD
Lapatinib—ERBB4—Disease—FGFR3—germ cell cancer	6.32e-05	0.000357	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—HRAS—germ cell cancer	6.3e-05	0.000356	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—KIT—germ cell cancer	6.29e-05	0.000355	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—HRAS—germ cell cancer	6.27e-05	0.000354	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—germ cell cancer	6.18e-05	0.000349	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KITLG—germ cell cancer	6.05e-05	0.000342	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KITLG—germ cell cancer	5.96e-05	0.000337	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AVP—germ cell cancer	5.91e-05	0.000334	CbGpPWpGaD
Lapatinib—ERBB2—Disease—KIT—germ cell cancer	5.9e-05	0.000333	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—germ cell cancer	5.89e-05	0.000333	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—HRAS—germ cell cancer	5.89e-05	0.000333	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—HRAS—germ cell cancer	5.89e-05	0.000333	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—HRAS—germ cell cancer	5.84e-05	0.00033	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AVP—germ cell cancer	5.82e-05	0.000329	CbGpPWpGaD
Lapatinib—ERBB4—Disease—KIT—germ cell cancer	5.81e-05	0.000328	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	5.8e-05	0.000328	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—HRAS—germ cell cancer	5.79e-05	0.000327	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—FGFR3—germ cell cancer	5.77e-05	0.000326	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—HRAS—germ cell cancer	5.76e-05	0.000326	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—HRAS—germ cell cancer	5.57e-05	0.000315	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—FGFR3—germ cell cancer	5.54e-05	0.000313	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FGF4—germ cell cancer	5.51e-05	0.000311	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—HRAS—germ cell cancer	5.46e-05	0.000308	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—HRAS—germ cell cancer	5.36e-05	0.000303	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—KIT—germ cell cancer	5.3e-05	0.000299	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—germ cell cancer	5.22e-05	0.000295	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—KIT—germ cell cancer	5.09e-05	0.000287	CbGpPWpGaD
Lapatinib—EGFR—Disease—FGF4—germ cell cancer	5.08e-05	0.000287	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—germ cell cancer	5.05e-05	0.000285	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SLC2A3—germ cell cancer	4.96e-05	0.00028	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—SLC22A3—germ cell cancer	4.88e-05	0.000276	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AVP—germ cell cancer	4.84e-05	0.000273	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—HRAS—germ cell cancer	4.74e-05	0.000268	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—HRAS—germ cell cancer	4.67e-05	0.000264	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—HRAS—germ cell cancer	4.55e-05	0.000257	CbGpPWpGaD
Lapatinib—EGFR—Disease—H2AFZ—germ cell cancer	4.54e-05	0.000256	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KITLG—germ cell cancer	4.52e-05	0.000255	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—FGFR3—germ cell cancer	4.5e-05	0.000254	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—HRAS—germ cell cancer	4.48e-05	0.000253	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—FGFR3—germ cell cancer	4.43e-05	0.00025	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SLC2A3—germ cell cancer	4.29e-05	0.000243	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—SLC22A3—germ cell cancer	4.23e-05	0.000239	CbGpPWpGaD
Lapatinib—EGFR—Disease—KITLG—germ cell cancer	4.18e-05	0.000236	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—OXT—germ cell cancer	4.17e-05	0.000236	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KIT—germ cell cancer	4.13e-05	0.000233	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KIT—germ cell cancer	4.07e-05	0.00023	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—HRAS—germ cell cancer	4.02e-05	0.000227	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CRABP1—germ cell cancer	3.98e-05	0.000225	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SLC2A3—germ cell cancer	3.83e-05	0.000216	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—SLC22A3—germ cell cancer	3.78e-05	0.000213	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SLC2A3—germ cell cancer	3.74e-05	0.000211	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—SLC22A3—germ cell cancer	3.69e-05	0.000208	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	3.68e-05	0.000208	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—HRAS—germ cell cancer	3.63e-05	0.000205	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	3.56e-05	0.000201	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGF4—germ cell cancer	3.56e-05	0.000201	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CRABP1—germ cell cancer	3.45e-05	0.000195	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FGFR3—germ cell cancer	3.36e-05	0.00019	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MYC—germ cell cancer	3.24e-05	0.000183	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MYC—germ cell cancer	3.2e-05	0.00018	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—H2AFZ—germ cell cancer	3.18e-05	0.00018	CbGpPWpGaD
Lapatinib—EGFR—Disease—FGFR3—germ cell cancer	3.1e-05	0.000175	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KIT—germ cell cancer	3.09e-05	0.000174	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CRABP1—germ cell cancer	3.08e-05	0.000174	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CRABP1—germ cell cancer	3e-05	0.00017	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.93e-05	0.000165	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KITLG—germ cell cancer	2.92e-05	0.000165	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AVP—germ cell cancer	2.86e-05	0.000161	CbGpPWpGaD
Lapatinib—EGFR—Disease—KIT—germ cell cancer	2.85e-05	0.000161	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HRAS—germ cell cancer	2.76e-05	0.000156	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HRAS—germ cell cancer	2.72e-05	0.000153	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HRAS—germ cell cancer	2.59e-05	0.000146	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HRAS—germ cell cancer	2.55e-05	0.000144	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HRAS—germ cell cancer	2.51e-05	0.000142	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC2A3—germ cell cancer	2.31e-05	0.00013	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—HRAS—germ cell cancer	2.29e-05	0.000129	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MYC—germ cell cancer	2.27e-05	0.000128	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—SLC22A3—germ cell cancer	2.27e-05	0.000128	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MYC—germ cell cancer	2.24e-05	0.000126	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HRAS—germ cell cancer	2.2e-05	0.000124	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—FGFR3—germ cell cancer	2.17e-05	0.000123	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KIT—germ cell cancer	2e-05	0.000113	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—germ cell cancer	1.87e-05	0.000105	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CRABP1—germ cell cancer	1.85e-05	0.000105	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—germ cell cancer	1.84e-05	0.000104	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HRAS—germ cell cancer	1.78e-05	0.000101	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HRAS—germ cell cancer	1.76e-05	9.92e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MYC—germ cell cancer	1.57e-05	8.86e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—HRAS—germ cell cancer	1.46e-05	8.24e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HRAS—germ cell cancer	1.33e-05	7.53e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—HRAS—germ cell cancer	1.23e-05	6.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MYC—germ cell cancer	1.1e-05	6.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—germ cell cancer	9.02e-06	5.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HRAS—germ cell cancer	8.62e-06	4.87e-05	CbGpPWpGaD
